Live attenuated viral vaccines for Eastern Equine Encephalitis virus
View Patent ↗Live attenuated Eastern Equine Encephalitis (EEE) vaccines that outperform the PE-6 vaccine in mice aerosol challenged with >1,000×LD50. Candidates include four furin-cleavage deletion mutants and one E3 deletion mutant. Each vaccine provided protection in birds against antigenically distinct North and South American strains of EEE. The PE-6 vaccine does not provide protection against South American EEEs. Animals inoculated with each of the vaccines of the invention developed neutralizing antibodies to EEE.
1. An isolated and purified DNA of SEQ ID NO. 1 comprising an FL91-4679 eastern equine encephalitis (EEE) virus cDNA fragment coding for infectious eastern equine encephalitis virus RNA genome, wherein said cDNA fragment coding for infectious eastern equine encephalitis virus RNA genome contains a deletion of the furin cleavage site and a suppressor mutation(s) in E1, E2 and/or E3.
2. The DNA according to claim 1 , wherein said EEE cDNA fragment is operably linked to a promoter such that said cDNA is transcribed.
3. An isolated and purified attenuated EEE virus RNA transcript encoded by the cDNA fragment of claim 1 .
4. Isolated and purified attenuated EEE virus particles containing an RNA transcript according to claim 1 .
5. A live attenuated eastern equine encephalitis (EEE) virus vaccine comprising attenuated EEE virus according to claim 4 .
6. A pharmaceutical formulation comprising attenuated EEE virus particles according to claim 4 in an effective immunogenic amount in a pharmaceutically acceptable carrier.
7. An inactivated EEE vaccine comprising attenuated EEE according to claim 4 wherein said attenuated EEE is inactivated.
8. A live attenuated eastern equine encephalitis virus vaccine comprising an isolated and purified DNA comprising one or more of the candidates selected from the group consisting of (1) a DNA comprising an eastern equine encephalitis virus cDNA fragment coding for infectious FL91-4679 eastern equine encephalitis virus RNA genome, wherein said cDNA fragment contains a deletion in the furin cleavage site and one or more suppressor mutations in E1, E2 and/or E3, (2) a DNA comprising an FL91-4679 eastern equine encephalitis virus cDNA fragment coding for infectious eastern equine encephalitis virus genome, wherein said cDNA fragment contains a partial deletion of the furin cleavage site and one or more suppressor mutations in E1, E2 and/or E3, and (3) a DNA comprising an FL91-4679 eastern equine encephalitis virus cDNA fragment coding for infectious eastern equine encephalitis virus genome, wherein said cDNA fragment contains a four amino acid deletion from codons 21-24 of the E3 gene.
9. A live attenuated eastern equine encephalitis virus vaccine comprising—one or more of an isolated and purified DNA of SEQ ID NO. 1 of eastern equine encephalitis virus cDNA fragment coding for infectious eastern equine encephalitis virus genome, wherein said one or more DNA is selected from the group consisting of: (1) said DNA, wherein said cDNA contains a deletion of the furin cleavage site and a suppressor mutation of a substitution of an aspartic acid at codon 174 of E2 gene to an alanine, (2) said DNA, wherein said cDNA contains a deletion of the furin cleavage site and a suppressor mutation of a substitution of a lysine at codon 186 of E2 gene to an asparagines, (3) said DNA, wherein said cDNA contains a deletion of the furin cleavage site and a suppressor mutation of a substitution of an isoleucine at codon 116 of E1 gene to a threonine, (4) said DNA, wherein said cDNA contains a deletion of the furin cleavage site and a suppressor mutation of a substitution of a histidine at codon 82 of E2 gene to an arginine, (5) said DNA, wherein said cDNA contains a deletion of the furin cleavage site and a suppressor mutation of a substitution of an asparagine at codon 230 of E2 gene to a serine, (6) said DNA, wherein said cDNA contains a deletion of the furin cleavage site and a suppressor mutation of a substitution of a proline at codon 303 of E2 gene to a glutamine, (7) said DNA, wherein said cDNA contains a deletion of the furin cleavage site and a suppressor mutation of a substitution of an isoleucine at codon 116 of E1 gene to an aspargagine, (8) said DNA, wherein said cDNA contains a deletion of the furin cleavage site and a suppressor mutation of a deletion of a histidine at codon 167 of E2 gene, (9) wherein said cDNA fragment contains a partial deletion of the furin cleavage site and a suppressor mutation of a substitution of a histidine at codon 82 of E2 gene to an arginine, (10) wherein said cDNA fragment contains a partial deletion of the furin cleavage site and a suppressor mutation of a deletion of a histidine at codon 167 of E2 gene, (11) wherein said cDNA fragment contains a partial deletion of the furin cleavage site and a suppressor mutation of a substitution of an arginine at codon 59 of E3 gene to a serine, (12) wherein said cDNA fragment contains a partial deletion of the furin cleavage site and a suppressor mutation of a substitution of an asparagine at codon 80 of E2 gene to an aspartic acid, and (13) wherein said cDNA fragment contains a four amino acid deletion from codons 21-24 in an E3 gene.
10. The vaccine of claim 7 , wherein said vaccine comprises a pharmaceutically acceptable carrier.
11. An isolated and purified DNA of SEQ ID NO. 1 of eastern equine encephalitis (EEE) virus cDNA fragment coding for infectious eastern equine encephalitis virus RNA genome and containing a deletion of the furin cleavage site and a suppressor mutation, said suppressor mutation comprising:
a substitution of aspartic acid at codon 174 in E2 protein to an alanine, said E2 protein recited in SEQ ID NO. 1.
12. An isolated and purified DNA of SEQ ID NO. 1 of eastern equine encephalitis (EEE) virus cDNA fragment coding for infectious eastern equine encephalitis virus RNA genome and containing a deletion of the furin cleavage site and a suppressor mutation, said suppressor mutation comprising:
a substitution of lysine at codon 186 in E2 protein to an asparagine, said E2 protein recited in SEQ ID NO. 1.
13. An isolated and purified DNA of SEQ ID NO. 1 of eastern equine encephalitis (EEE) virus cDNA fragment coding for infectious eastern equine encephalitis virus RNA genome and containing a deletion of the furin cleavage site and a suppressor mutation, said suppressor mutation comprising:
a substitution of isoleucine at codon 116 in E1 protein to a threonine, said E1 protein recited in SEQ ID NO. 1.
14. An isolated and purified DNA of SEQ ID NO. 1 of eastern equine encephalitis (EEE) virus cDNA fragment coding for infectious eastern equine encephalitis virus RNA genome and containing a deletion of the furin cleavage site and a suppressor mutation, said suppressor mutation comprising:
a substitution of histidine at codon 82 in E2 protein to an arginine, said E2 protein recited in SEQ ID NO. 1.
15. An isolated and purified DNA of SEQ ID NO. 1 of eastern equine encephalitis (EEE) virus cDNA fragment coding for infectious eastern equine encephalitis virus RNA genome and containing a deletion of the furin cleavage site and a suppressor mutation, said suppressor mutation comprising:
a substitution of an asparagine at codon 230 in E2 protein to a serine, said E2 protein recited in SEQ ID NO. 1.
16. An isolated and purified DNA of SEQ ID NO. 1 of eastern equine encephalitis (EEE) virus cDNA fragment coding for infectious eastern equine encephalitis virus RNA genome and containing a deletion of the furin cleavage site and a suppressor mutation, said suppressor mutation comprising:
a substitution of proline at codon 303 in E2 protein to a glutamine, said E2 protein recited in SEQ ID NO. 1.
17. An isolated and purified DNA of SEQ ID NO. 1 of eastern equine encephalitis (EEE) virus cDNA fragment coding for infectious eastern equine encephalitis virus RNA genome and containing a deletion of the furin cleavage site and a suppressor mutation, said suppressor mutation comprising:
a substitution of an isoleucine at codon 116 in E1 protein to an asparagine, said E1 protein recited in SEQ ID NO. 1.
18. An isolated and purified DNA of SEQ ID NO. 1 of eastern equine encephalitis (EEE) virus cDNA fragment coding for infectious eastern equine encephalitis virus RNA genome and containing a deletion of the furin cleavage site and a suppressor mutation, said suppressor mutation comprising:
a deletion of the histidine at codon 167 in E2 protein, said E2 protein recited in SEQ ID NO. 1.